Chongqing Hongjiu Fruit Co., Limited
6689.HK News Today: Stay Updated with the Latest Chongqing Hongjiu Fruit Co., Limited News in Real Time
Find 6689.HK news now at Meyka AI. Stay informed with the latest Chongqing Hongjiu Fruit Co., Limited stocks updates, including price news, market analysis, and expert insights.
FJTSY Fujitsu Limited Earnings Preview April 30, 2026
Fujitsu Limited (FJTSY) earnings preview for April 30, 2026. EPS estimate $0.4791, revenue estimate $7.22B. What to watch.
PLTR Stock Drops 1.34% Pre-Market as May 4 Earnings Loom
PLTR stock falls 1.34% in pre-market trading at $141.18 ahead of May 4 earnings announcement. Analyst consensus remains mixed.
AIG Earnings Preview: April 30 Report, $1.90 EPS Expected
AIG earnings preview for April 30, 2026. Analysts expect $1.90 EPS and $7.03B revenue. See what to watch.
IDEA.NS stock surges 6.81% on NSE as Vodafone Idea gains momentum
IDEA.NS stock jumped 6.81% to INR 10.35 on NSE today. Vodafone Idea Limited shows strong trading activity with 393.8M shares traded.
EDV.TO Earnings Preview: Endeavour Mining Q1 2026 April 30
Endeavour Mining (EDV.TO) reports Q1 2026 earnings April 30. Analysts expect $2.07 EPS and $1.83B revenue. Gold miner faces margin pressure.
Humana Stock Jumps as Q Results Beat Estimates, Profit Hits $10.31 EPS
On April 29, 2026, Humana Inc. released its Q1 2026 earnings report, and the results caught Wall Street’s attention. The healthcare company reported earnings per share of $10.31, beating market expectations and lifting investor confidence. Following the announcement, Humana stock moved higher in early trading as investors reacted to the stronger-than-expected performance. The company also…
ExaWizards Inc. 4259.T Closes Up 1.84% on JPX April 29
4259.T stock price rises ¥13 to ¥721 on JPX. ExaWizards Inc. AI platform services show mixed signals with B grade rating.
RBLX Earnings Preview: Roblox Q1 2026 on April 30
Roblox earnings preview: Analysts expect -$0.43 EPS and $1.74B revenue on April 30. Stock down 2.45% today.
ALNY Earnings Preview: Alnylam Q1 2026 on April 30
Alnylam Pharmaceuticals (ALNY) reports Q1 2026 earnings April 30. Analysts expect $1.43 EPS and $1.12B revenue. Stock down 24% YTD.